ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

IRB/UVA Tracking #
17717
Contact
Candace K Hudspeth
Contact Email
Contact Phone
1.434.982.1091
Phase
III
Primary purpose
Treatment
Cancer PI
William C. Petersen
Status
OPEN TO ACCRUAL
Ages
Children